EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway

Lin Du, Baojun Wang, Mengtong Wu, Weixu Chen, Wendi Wang, Wenli Diao, Meng Ding, Wei Chen, Wenmin Cao, Hongqian Guo, Gutian Zhang

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Lin Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanjing Drum Tower Hospital Clinical College of Southeast University, Nanjing, 210008, Jiangsu, China; Department of Urology, …. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of long non-coding RNA (lncRNA) in the progression of renal cell carcinoma (RCC) remains further study. Whether lncRNA may be used to predict the immunotherapy efficacy of RCC is less studied. In this study, LINC00926 was found to be mainly located in cytoplasm by FISH and RNA nuclear-cytoplasmic fractionation. Downregulation of LINC00926 in RCC cell lines inhibited the progression and metastasis of RCC cells. RNA pull-down assay and dual-luciferase reporter assay demonstrated that LINC00926 functioned as miR-30a-5p sponge to facilitate SOX4 expression. LINC00926 overexpression in BALB/c mice enhanced PD-L1 surface expression and resulted in immune escape. Mechanistic investigations showed that LINC00926 competitively bound to Lyn, leading to the inhibition of CBL-mediated ubiquitination and degradation, and stabilized Lyn, contributing to the activation of IFNγ-JAK2-STAT1 signaling pathway. Moreover, LINC00926, together with PD-L1 or PD-1 expression, may predict the overall survival in RCC patients. Therefore, LINC00926 has the potential to be a novel therapeutic target and a biomarker to predict ICB immunotherapy response in RCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsMicroRNAsRNA, Long NoncodingAnimalsHumansMiceB7-H1 AntigenCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticJanus Kinase 2SOXC Transcription FactorsSTAT1 Transcription Factor

Stichwörter der Autor:innen

Immune escapeLINC00926Renal cell carcinomalncRNA

Substanzen

B7-H1 AntigenJAK2 protein, humanJanus Kinase 2MicroRNAsRNA, Long NoncodingSOX4 protein, humanSOXC Transcription FactorsSTAT1 protein, humanSTAT1 Transcription Factor

Autor:innen und Institutionen

  • Department of Urology, Nanjing Drum Tower Hospital Clinical College of Southeast University, Nanjing, 210008, Jiangsu, China; Department of Urology, The First People's Hospital of Yancheng, Yancheng, 224006, Jiangsu, Ch…
  • Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230039, Anhui, China; Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicin…
  • Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, Jiangsu, China.
  • Department of Urology, Nanjing Drum Tower Hospital Clinical College of Southeast University, Nanjing, 210008, Jiangsu, China.
  • Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, Nanjing, 210008, Jiangsu, China.
  • Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, Nanjing, 210008, Jiangsu, China. Electronic address: dr.ghq@nju.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Du, L., Wang, B., Wu, M., Chen, W., Wang, W., Diao, W., Ding, M., Chen, W., Cao, W., Guo, H., & Zhang, G. (2023). LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216463

Vancouver

Du L, Wang B, Wu M, Chen W, Wang W, Diao W, et al. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216463

BibTeX
@article{Du2023,
  author = {Du, Lin and Wang, Baojun and Wu, Mengtong and Chen, Weixu and Wang, Wendi and Diao, Wenli and Ding, Meng and Chen, Wei and Cao, Wenmin and Guo, Hongqian and Zhang, Gutian},
  title = {LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216463}
}
Kostenlos starten →